 | Up a level |
Anderson, Simon G and Hutchings, David C and Woodward, Mark and Rahimi, Kazem and Rutter, Martin K and Kirby, Mike and Hackett, Geoffrey and Trafford, Andrew W and Heald, Adrian H (2016) Phosphodiesterase type-5 inhibitor use in type 2 diabetes is associated with a reduction in all-cause mortality. Heart (British Cardiac Society), 102 (21). pp. 1750-1756. ISSN 1468-201X. This article is available to all HEFT staff and students via ASK HEFT Discovery tool http://tinyurl.com/z795c8c using their HEFT Athens Login.
